Estonia - estoniană - Ravimiamet

bausch + lomb ireland limited - moksifloksatsiin - silmatilgad, lahus - 5mg 1ml 5ml 1tk

Estonia - estoniană - Ravimiamet

mcneil healthcare (ireland) limited - ksülometasoliin+dekspantenool - ninasprei, lahus - 0,5mg+50mg 1ml 10ml 1tk

Estonia - estoniană - Ravimiamet

aspen pharma trading limited - östriool - vaginaalsuposiit - 500mcg 30tk; 500mcg 15tk

Estonia - estoniană - Ravimiamet

bausch + lomb ireland limited - brinsolamiid - silmatilgad, suspensioon - 10mg 1ml 5ml 3tk

Estonia - estoniană - Ravimiamet

bausch health ireland limited - tsefprosiil - õhukese polümeerikattega tablett - 250mg 10tk

Estonia - estoniană - Ravimiamet

mcneil healthcare (ireland) limited - ksülometasoliin+dekspantenool - ninasprei, lahus - 1mg+50mg 1ml 10ml 1tk

Estonia - estoniană - Ravimiamet

bausch health ireland limited - tsefprosiil - õhukese polümeerikattega tablett - 500mg 10tk

Uniunea Europeană - estoniană - EMA (European Medicines Agency)

mylan ireland limited - asatsitidiin - myelodysplastic syndromes; leukemia, myelomonocytic, chronic; leukemia, myeloid, acute - antineoplastilised ained - azacitidine mylan is indicated for the treatment of adult patients who are not eligible for haematopoietic stem cell transplantation (hsct) with:intermediate 2 and high risk myelodysplastic syndromes (mds) according to the international prognostic scoring system (ipss),chronic myelomonocytic leukaemia (cmml) with 10 29% marrow blasts without myeloproliferative disorder,acute myeloid leukaemia (aml) with 20 30% blasts and multi lineage dysplasia, according to world health organisation (who) classification,aml with > 30% marrow blasts according to the who classification.

Estonia - estoniană - Ravimiamet

pharmaswiss ceska republika s.r.o. - takroliimus - kõvakapsel - 1mg 30tk; 1mg 90tk; 1mg 20tk; 1mg 60tk; 1mg 100tk

Estonia - estoniană - Ravimiamet

pharmaswiss ceska republika s.r.o. - takroliimus - kõvakapsel - 0,5mg 30tk; 0,5mg 50tk; 0,5mg 60tk; 0,5mg 20tk; 0,5mg 100tk